HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K252a inhibits the oncogenic properties of Met, the HGF receptor.

Abstract
The ATP analog K252a is a potent inhibitor for receptor tyrosine kinases of the Trk family. Here we show that nanomolar concentrations of K252a prevent HGF-mediated scattering in MLP-29 cells (30 nM), reduce Met-driven proliferation in GTL-16 gastric carcinoma cells (100 nM), and cause reversion in NIH3T3 fibroblasts transformed by the oncogenic form of the receptor, Tpr-Met (75 nM). K252a inhibits Met autophosphorylation in cultured cells and in immunoprecipitates and prevents activation of its downstream effectors MAPKinase and Akt. Interestingly, K252a seems to be more effective at inhibiting the mutated form of Met (M1268T) found in papillary carcinoma of the kidney than the wild type receptor. Pretreatment of both Tpr-Met-transformed NIH3T3 fibroblasts and of GTL-16 gastric carcinoma cells with K252a results in loss of their ability to form lung metastases in nude mice upon injection into the caudal vein. These observations suggest that K252a derivatives, which are active in vivo as anti-cancer drugs in models of Trk-driven malignancies, should also be effective for treatment of Met-mediated tumors.
AuthorsAlessandro Morotti, Silvia Mila, Paolo Accornero, Emma Tagliabue, Carola Ponzetto
JournalOncogene (Oncogene) Vol. 21 Issue 32 Pg. 4885-93 (Jul 25 2002) ISSN: 0950-9232 [Print] England
PMID12118367 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carbazoles
  • Enzyme Inhibitors
  • Indole Alkaloids
  • staurosporine aglycone
  • Proto-Oncogene Proteins c-met
  • Protein Kinase C
Topics
  • 3T3 Cells
  • Animals
  • Carbazoles (pharmacology)
  • Cell Transformation, Neoplastic (drug effects)
  • Enzyme Inhibitors (pharmacology)
  • Humans
  • Indole Alkaloids
  • Lung Neoplasms (prevention & control, secondary)
  • Mice
  • Neoplasms, Experimental (prevention & control)
  • Phosphorylation (drug effects)
  • Protein Kinase C (antagonists & inhibitors)
  • Proto-Oncogene Proteins c-met (antagonists & inhibitors)
  • Signal Transduction (drug effects)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: